Technical Analysis for AIM - AIM ImmunoTech Inc.

Grade Last Price % Change Price Change
grade C 3.07 2.68% 0.08
AIM closed up 2.4 percent on Friday, August 7, 2020, on approximately normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical AIM trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 2.68%
Stochastic Buy Signal Bullish 2.68%
Pocket Pivot Bullish Swing Setup 2.68%
Outside Day Range Expansion 2.68%
Wide Bands Range Expansion 2.68%
Oversold Stochastic Weakness 2.68%
20 DMA Resistance Bearish 5.14%
Wide Bands Range Expansion 5.14%
Oversold Stochastic Weakness 5.14%
Wide Bands Range Expansion 4.78%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen, a drug of macromolecular ribonucleic acid molecule for the treatment of chronic fatigue syndrome. It is also developing Ampligen for the treatment of Hepatitis B and HIV, as well as patients with renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, urothelial, prostate, and pancreatic cancer. AIM ImmunoTech Inc. has agreements with UMN Pharma Inc., Japan National Institute of Infectious Diseases, and Shionogi & Co., Ltd. for the evaluation and discussion of business relationships concerning a COVID-19 therapeutic and vaccine. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida.
Medicine Disease Cancers Health Care HIV Pancreatic Cancer Hepatitis B Renal Cell Carcinoma Treatment Of Hepatitis B

Is AIM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.11
52 Week Low 0.381
Average Volume 6,128,722
200-Day Moving Average 1.76
50-Day Moving Average 2.74
20-Day Moving Average 3.01
10-Day Moving Average 2.94
Average True Range 0.29
ADX 31.93
+DI 30.57
-DI 17.04
Chandelier Exit (Long, 3 ATRs ) 3.44
Chandelier Exit (Short, 3 ATRs ) 3.27
Upper Bollinger Band 3.60
Lower Bollinger Band 2.43
Percent B (%b) 0.48
BandWidth 38.93
MACD Line 0.06
MACD Signal Line 0.09
MACD Histogram -0.036
Fundamentals Value
Market Cap 87.24 Million
Num Shares 29.2 Million
EPS -0.37
Price-to-Earnings (P/E) Ratio -8.15
Price-to-Sales 27.86
Price-to-Book 0.90
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.41
Resistance 3 (R3) 3.40 3.25 3.34
Resistance 2 (R2) 3.25 3.14 3.26 3.32
Resistance 1 (R1) 3.12 3.08 3.19 3.13 3.29
Pivot Point 2.97 2.97 3.00 2.98 2.97
Support 1 (S1) 2.84 2.86 2.91 2.85 2.69
Support 2 (S2) 2.69 2.80 2.70 2.66
Support 3 (S3) 2.56 2.69 2.64
Support 4 (S4) 2.57